News

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.
The HHS will require all new vaccines to undergo placebo-controlled trials, likely slowing down approvals and decreasing access.
More pediatric deaths have happened in 2025 than any other year since 2009, reflecting a drop in childhood vaccination rates.
The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).
The HIV-1 trimer vaccine induced mild-to-moderate adverse effects, exhibiting a similar safety profile to other approved mRNA vaccines.
The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...
The majority of patients with advanced melanoma who stop treatment with immune checkpoint inhibitor therapies remain relapse-free.
Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.
Power outages longer than four hours, especially large-scale ones, increased the risk for pediatric carbon monoxide poisoning.
The use of HMME-PDT is associated with a positive response and is well-tolerated among patients with facial port-wine stains.
Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.
Buprenorphine reduced severe maternal morbidity, preterm births, and NICU admissions in pregnant women with opioid use disorder.